![](https://investorshub.advfn.com/uicon/174004.png?cb=1465028948)
Wednesday, March 01, 2017 10:48:08 AM
"Yes it is. With the stock price held so artificially low for the past year or so due to toxic lenders, we cut back compensation to our officers and directors, whose only compensation is stock warrants. As a result, we received only a fraction of the intended dollar equivalent position compensation. This was done to mitigate, albeit in a small way, the dilution that had been going on due to debt conversions.
The best news of all is that our long term equity debt has been effectively eliminated, and the excessive dilution we were seeing should be at an end. We still need money to operate the company, but we will be much more judicious in any future loans.
Thank you for your continued interest in Premier Biomedical."
Unreal
BIEI
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM